Literature DB >> 21252528

Pathogenesis of tubular interstitial nephritis.

Tetsuhiro Tanaka, Masaomi Nangaku.   

Abstract

Injury to the interstitium of the kidney is regarded as a common pathway leading to end-stage renal insufficiency, regardless of etiology. Tubular interstitial nephritis is characterized histologically by inflammatory changes in the tubulointerstitial compartment, such as interstitial edema, leukocyte infiltration, accumulation of extracellular matrix proteins, tubular dilation and atrophy. Acute interstitial nephritis is often associated with use of drugs, such as β-lactam antibiotics and non-steroidal anti-inflammatory drugs, and is likely mediated through allergic mechanisms. On the other hand, chronic progressive tubular interstitial nephritis has a much more diverse etiology, ranging from infection and drugs to immune-mediated, hematologic, metabolic and hereditary disorders. Experimental studies in the past decade have focused mainly on common factors and mechanisms underlying chronic tubulointerstitial injury, such as activation of peritubular fibroblasts, leukocyte infiltration, release of inflammatory cytokines and growth factors at affected regions, epithelial-mesenchymal transition of tubular epithelium, and apoptosis. The execution of each is mediated by a number of local stimuli, such as filtered albumin, chronic hypoxia and oxidative stress, in addition to cytokines and growth factors. This chapter provides an overview of acute and chronic tubular interstitial nephritis, according to clinical manifestations of the disease. It also provides insight into common pathways underlying chronic tubular interstitial nephritis based on recent advances in translational and experimental research.
Copyright © 2011 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21252528     DOI: 10.1159/000314577

Source DB:  PubMed          Journal:  Contrib Nephrol        ISSN: 0302-5144            Impact factor:   1.580


  6 in total

1.  Leukocyte Cell-Derived Chemotaxin 2-Associated Renal Amyloidosis: A Case Report.

Authors:  Gagandeep Kaur; Babitha Bijin; Kamron Saleem; Benjamin Sarsah; Bijin Thajudeen
Journal:  Case Rep Nephrol Dial       Date:  2017-12-11

Review 2.  New Biomarkers in Acute Tubulointerstitial Nephritis: A Novel Approach to a Classic Condition.

Authors:  Laura Martinez Valenzuela; Juliana Draibe; Xavier Fulladosa; Juan Torras
Journal:  Int J Mol Sci       Date:  2020-06-30       Impact factor: 5.923

3.  Drug-induced tubulointerstitial nephritis in a retrospective study using spontaneous reporting system database.

Authors:  Saki Oyama; Keiko Hosohata; Ayaka Inada; Iku Niinomi; Yasuhiro Mori; Yuki Yamaguchi; Mayako Uchida; Kazunori Iwanaga
Journal:  Ther Clin Risk Manag       Date:  2018-09-05       Impact factor: 2.423

4.  Telocytes in the human kidney cortex.

Authors:  Guisheng Qi; Miao Lin; Ming Xu; C G Manole; Xiangdong Wang; Tongyu Zhu
Journal:  J Cell Mol Med       Date:  2012-12       Impact factor: 5.310

5.  Baicalein alleviates tubular-interstitial nephritis in vivo and in vitro by down-regulating NF-κB and MAPK pathways.

Authors:  Yan Chen; Yu Zheng; Zhihong Zhou; Jinjun Wang
Journal:  Braz J Med Biol Res       Date:  2018-08-06       Impact factor: 2.590

Review 6.  The Role of Notch3 Signaling in Kidney Disease.

Authors:  Cheng Yuan; Lihua Ni; Changjiang Zhang; Xiaoyan Wu
Journal:  Oxid Med Cell Longev       Date:  2020-10-22       Impact factor: 6.543

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.